Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
820,374
-
Share change
-
-1,251,855
-
Total reported value
-
$137,342
-
Price per share
-
$0.17
-
Number of holders
-
15
-
Value change
-
-$161,416
-
Number of buys
-
2
-
Number of sells
-
15
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q1 2023
As of 31 Mar 2023,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
820,374 shares.
The largest 10 holders included
MORGAN STANLEY, GROUP ONE TRADING, L.P., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, Virtu Financial LLC, ADVISOR GROUP HOLDINGS, INC., Affinity Capital Advisors, LLC, HBK Sorce Advisory LLC, TWO SIGMA INVESTMENTS, LP, and Spectrum Planning & Advisory Services Inc..
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.